HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.

Abstract
Peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear receptor superfamily member, plays a major role in lipid metabolism and insulin sensitivity. We investigated the role of PPARgamma in colonic epithelial cell turnover and carcinogenesis in colon because PPARgamma is strongly expressed in colonic epithelium. Administration of PPARgamma agonists suppressed epithelial cell turnover in mice. Expression level of beta-catenin protein, a key molecule in carcinogenesis, was increased in mouse colon treated with PPARgamma ligands. A direct interaction between beta-catenin and PPARgamma in cultured cell lines and colonic epithelium in mice was observed. Ligand-activated PPARgamma ligand directly interacts with beta-catenin, retaining it in the cytosol and reducing beta-catenin/T cell factor (TCF) transcriptional activity that is functionally important on aberrant crypt foci (ACF) formation. PPARgamma hetero-deficiency promoted the induction of ACF, but had no effect on the incidence of colonic polyps. These results indicate that PPARgamma regulates colonic epithelial cell turnover via direct interactions with beta-catenin, resulting in inhibition of beta-catenin-mediated transcriptional pathways that are involved in promoting cell proliferation. Our findings suggest that PPARgamma plays a role as a physiological regulator of colonic epithelial cell turnover and consequently predisposition to the development of colon cancer in early stage.
AuthorsToshio Fujisawa, Atsushi Nakajima, Nobutaka Fujisawa, Hirokazu Takahashi, Ikuko Ikeda, Ayako Tomimoto, Kyoko Yonemitsu, Noriko Nakajima, Chiho Kudo, Koichiro Wada, Naoto Kubota, Yasuo Terauchi, Takashi Kadowaki, Hitoshi Nakagama, Richard S Blumberg
JournalJournal of pharmacological sciences (J Pharmacol Sci) Vol. 106 Issue 4 Pg. 627-38 (Apr 2008) ISSN: 1347-8613 [Print] Japan
PMID18391483 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • CTNNB1 protein, human
  • CTNNB1 protein, mouse
  • PPAR gamma
  • TCF Transcription Factors
  • Thiazolidinediones
  • beta Catenin
  • Azoxymethane
  • Pioglitazone
Topics
  • Active Transport, Cell Nucleus
  • Animals
  • Azoxymethane
  • Caco-2 Cells
  • Cell Proliferation (drug effects)
  • Cell Transformation, Neoplastic (drug effects, metabolism, pathology)
  • Colon (drug effects, metabolism, pathology)
  • Colonic Neoplasms (chemically induced, metabolism, pathology, prevention & control)
  • Epithelial Cells (drug effects, metabolism, pathology)
  • Female
  • HT29 Cells
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • PPAR gamma (agonists, genetics, metabolism)
  • Pioglitazone
  • Protein Binding
  • RNA Interference
  • Signal Transduction
  • TCF Transcription Factors (genetics, metabolism)
  • Thiazolidinediones (pharmacology)
  • Time Factors
  • Transfection
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: